Loading organizations...
§ Private Profile · Changshan, China
develops and manufactures automated medical devices and IVD products for molecular diagnostics, blood screening, and clinical testing.
IMADEK develops and manufactures automated medical devices and IVD products for molecular diagnostics, blood screening, and mass spectrometry, based in Changsha, Hunan Province, China, with an R&D center in Shenzhen. The company provides reliable, affordable equipment and consumables, including pipetting modules and fully automated sample processing systems, to enhance efficiency in clinical testing, blood banks, and life science laboratories. Operating a 103,000 square meter production plant in Changsha and a 700 square meter R&D center in Shenzhen, IMADEK reported annual revenue exceeding 70 million RMB. Their "Platform+Modularity" design supports diverse scenarios, with their first fully automatic sample processing system and intelligent blood bank commercialized in 2017. IMADEK recently secured Series A funding in February 2026. The organization was founded in 2016.
IMADEK develops automated products primarily for use in blood systems and in vitro diagnostics.
IMADEK develops automated laboratory equipment such as pipetting robots, designed for applications like ELISA and high-throughput processes.
IMADEK develops automated products primarily for use in blood systems and in vitro diagnostics.
IMADEK develops automated laboratory equipment such as pipetting robots, designed for applications like ELISA and high-throughput processes.
IMADEK most recently raised Series A in February 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 10, 2026 | Series A | Green Pine Capital Partners, Hongchuang Capital | — | Announced |